Different Numbers of Long-Pulse 1064-nm Nd-YAG Laser Treatments for Onychomycosis: A Pilot Study

Abstract

Purpose. To examine the benefits of different numbers of 1064-nm Nd-YAG laser treatments in patients with onychomycosis. Methods. This was a pilot study of patients with onychomycosis who were divided into three groups: four treatment sessions (group A), eight sessions (group B), and 12 sessions (group C). Only infected nails of degrees II–III (Scoring Clinical Index for Onychomycosis) were included. Treatment was given once a week using a long-pulse Nd-YAG 1064-nm laser. Patients were followed at 8, 16, and 24 weeks after the first treatment. Side effects were recorded. Results. Treatments were completed for 442 nails in 102 patients. The efficacy rates at 8, 16, and 24 weeks were 35.5%, 38.7%, and 37.4% for group A; 31.4%, 41.7%, and 44.0% for group B; and 27.7%, 50.0%, and 55.4% for group C, respectively. There was a significant difference in the efficacy rate at 24 weeks (P=0.016) between groups A and C, but not for groups A vs. B, or for groups B vs. C. No difference in the efficacy rate at 8 or 16 weeks was observed among the three groups. In all three groups, the efficacy was better for degree II nails than for degree III nails (all P<0.05). No side effects occurred. Conclusions. The 1064-nm Nd-YAG laser had clinical benefits against onychomycosis. Higher numbers of treatments provided better long-term (24-week) benefits, but had no impact on the short-term outcomes. The efficacy of laser treatment on degree II onychomycosis was better than for degree III.

The Effectiveness of Long-Pulse 1064 nm Nd-YAG Laser Therapy Combined With an Oral Itraconazole Capsule in the Treatment of Onychomycosis

“…10 In our study, the total effective rate of the 1064 nm Nd-YAG laser treatment group was 53.6%, which was consistent with previous studies. 9,10…”

Growth inhibition of Trichophyton rubrum by laser irradiation: exploring further experimental aspects in an in vitro evaluation study

“…Both groups were divided into three subgroups according to laser energy: 300, 408, and 600 J/cm 2 . Based on a previous study [ 18 ], 300 J/cm 2 is similar to the energy used clinically, 408 J/cm 2 is a little higher than the clinical energy, and 600 J/cm 2 is significantly higher than the clinical energy. Laser irradiation was administrated in a spiral pattern with a total of 200 spots (as shown in Fig.…”

“…Both groups were divided into three subgroups according to laser energy: 300, 408, and 600 J/cm 2 . Based on a previous study [18], Fig. 1 Laser scanning in the spiral pattern over the colony and repeated till 200 spots 300 J/cm 2 is similar to the energy used clinically, 408 J/ cm 2 is a little higher than the clinical energy, and 600 J/ cm 2 is significantly higher than the clinical energy.…”

The Efficacy of N-Acetylcysteine Combined With Budesonide/Formoterol in the Treatment of Stable Chronic Obstructive Pulmonary Disease

“…Reduced GSH is usually depleted in diseases associated with increased oxidative stress and inflammation, and NAC can maintain the antioxidant stress in vivo by restoring reduced GSH in cells. 9 The GOLD 2017 recommendation also suggests that NAC has the effect of reducing the number of acute episodes in COPD patients. 10 This study was performed to observe the pulmonary function of patients with a severe stable phase of COPD who were treated with budesonide and formoterol combined with or without NAC.…”

“…9 The GOLD 2017 recommendation also suggests that NAC has the effect of reducing the number of acute episodes in COPD patients. 10 This study was performed to observe the pulmonary function of patients with a severe stable phase of COPD who were treated with budesonide and formoterol combined with or without NAC. Our results demonstrated that the inhalation treatment of NAC combined with budesonide/formoterol significantly improved pulmonary function, blood gas analysis, serum oxidative stress, inflammation levels, and quality of life in patients with COPD compared with budesonide/formoterol inhalation alone.…”